semaglutide and cushing's Efficacy safety of GLP-1 receptor agonists in the treatment of type 2 diabetes and/or obesity in patients with syndrome: a multicenter retrospective study | Endocrine Medications like Semaglutide and Tirzepatide

You can skip the snacks

Telogen effluvium, a common form of hair loss, may occur due to metabolic stress from rapid weight loss

According to current guidance: GLP-1 medications are FDA-approved only for adolescents aged 12 and above with severe obesity (defined as a BMI of 120% or more of the 95th percentile)

Weight loss was also observed, with a modest correlation between alcohol reduction and weight change, suggesting GLP-1RAs may simultaneously target both alcohol use and obesity

This is especially important if you take diabetes medications like insulin or sulfonylureas , as using Wegovy alongside these treatments increases your risk of hypoglycaemia

This directly addresses the concern about semaglutide and muscle loss